Ambros Therapeutics, Inc.
Ambros Therapeutics, Inc.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 3, Open-Label Extension Study of AMBTX-01 (Neridronate) for Complex Regional Pain Syndrome Type 1 | Edema, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, autonomic nervous system disorder, complex regional pain syndrome, nervous system disorder, neuromuscular disease, peripheral nervous system disorder | Not yet recruiting | Phase 3 | 2026-10-05 | NCT07857733 | |
| CRPS-RISE Outcomes Registry | autonomic nervous system disorder, complex regional pain syndrome, complex regional pain syndrome type 1, nervous system disorder, neuromuscular disease, peripheral nervous system disorder | Recruiting | Not stated | 2026-09-29 | NCT07811362 | |
| Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE) | Edema, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, autonomic nervous system disorder, complex regional pain syndrome, complex regional pain syndrome type 1, nervous system disorder, neuromuscular disease, peripheral nervous system disorder | Recruiting | Phase 3 | 2026-09-10 | NCT07210515 |